Skip to main content

Table 10 Mean annual number of stable days and cost per patient by pharmaceutical treatment

From: Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: A cost effectiveness study

 

Paliperidone ER

Olanzapine

Risperidone

Quetiapine

Ziprasidone

Aripiprazole

Base case:

Cost (€)

7.030

7.034

7.082

8.321

7.713

7.807

Effectiveness

272.5

272.2

265.5

260.7

260.5

258.6

Incremental cost and effectiveness compared with paliperidone ER:

Cost (€)

-

4

52

1.291

683

777

Effectiveness

-

-0.3

-7.0

-11.8

-12.0

-13.9